Summary
UnitedHealth Group Inc. (UNH) reported its first quarter 2026 results, demonstrating steady revenue growth and robust earnings per share, though facing some membership contractions in key areas. Total revenues increased by 2% year-over-year to $111.7 billion, driven by price increases at UnitedHealthcare and growth at Optum Rx, offsetting declines in Medicare Advantage and Medicaid enrollment. Earnings from operations remained strong at $9.0 billion, with diluted earnings per share reaching $6.90, reflecting operational management and favorable reserve development despite increased operating costs. Significant strategic actions were undertaken, including portfolio divestitures and restructuring efforts, which resulted in net gains and impacts across segments like Optum Insight and Optum Health. While the company experienced a decline in the number of people served by UnitedHealthcare, particularly in Medicare Advantage and Medicaid, due to benefit design, pricing actions, and reduced eligibility, it also initiated forward share repurchase contracts and paid substantial dividends, indicating continued confidence and commitment to shareholder returns. The company is also actively pursuing pending acquisitions expected to close in the latter half of 2026.
Financial Highlights
54 data points| Revenue | $111.72B |
| Cost of Revenue | $12.82B |
| Gross Profit | $98.90B |
| SG&A Expenses | $15.39B |
| Operating Expenses | $102.73B |
| Operating Income | $8.99B |
| Interest Expense | $955.00M |
| Net Income | $6.28B |
| EPS (Basic) | $6.92 |
| EPS (Diluted) | $6.90 |
| Shares Outstanding (Basic) | 908.00M |
| Shares Outstanding (Diluted) | 910.00M |
Key Highlights
- 1Total revenues grew 2% to $111.7 billion for the three months ended March 31, 2026, compared to the prior year.
- 2Diluted earnings per share (EPS) increased to $6.90 from $6.85 in the prior year period.
- 3UnitedHealthcare served 1.1 million fewer people, primarily due to benefit design and pricing actions, and reduced Medicaid eligibility.
- 4Optum Health revenues saw a 3% decrease, largely due to fewer patients served under value-based arrangements.
- 5The company initiated forward share repurchase contracts totaling $500 million as of March 31, 2026.
- 6Cash flows from operating activities were robust, totaling $8.9 billion for the quarter.
- 7The company has pending acquisitions totaling approximately $3.0 billion expected to close in the second half of 2026.